Romeg patents expiration
1. Gloperba patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9907751 | ROMEG | Composition and method of use of colchicine oral liquid |
Nov, 2036
(13 years from now) | |
| US10383820 | ROMEG | Colchicine drug-to-drug interactions |
Nov, 2036
(13 years from now) | |
| US10383821 | ROMEG | Colchicine drug-to-drug interactions |
Nov, 2036
(13 years from now) | |
| US10226423 | ROMEG | Colchicine drug-to-drug interactions |
Dec, 2037
(14 years from now) | |
Drugs and Companies using COLCHICINE ingredient
Market Authorisation Date: 30 January, 2019
Treatment: A method of prophylactic treatment of gout flares in adults comprises administering to a patient a liquid colchicine oral solution
Dosage: SOLUTION;ORAL
How can I launch a generic of GLOPERBA before it's drug patent expiration?
More Information on Dosage
GLOPERBA family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic